HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.

Abstract
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by mutations in the SMN1 gene that result in a deficiency of SMN protein. One approach to treat SMA is to use antisense oligonucleotides (ASOs) to redirect the splicing of a paralogous gene, SMN2, to boost production of functional SMN. Injection of a 2'-O-2-methoxyethyl-modified ASO (ASO-10-27) into the cerebral lateral ventricles of mice with a severe form of SMA resulted in splice-mediated increases in SMN protein and in the number of motor neurons in the spinal cord, which led to improvements in muscle physiology, motor function and survival. Intrathecal infusion of ASO-10-27 into cynomolgus monkeys delivered putative therapeutic levels of the oligonucleotide to all regions of the spinal cord. These data demonstrate that central nervous system-directed ASO therapy is efficacious and that intrathecal infusion may represent a practical route for delivering this therapeutic in the clinic.
AuthorsMarco A Passini, Jie Bu, Amy M Richards, Cathrine Kinnecom, S Pablo Sardi, Lisa M Stanek, Yimin Hua, Frank Rigo, John Matson, Gene Hung, Edward M Kaye, Lamya S Shihabuddin, Adrian R Krainer, C Frank Bennett, Seng H Cheng
JournalScience translational medicine (Sci Transl Med) Vol. 3 Issue 72 Pg. 72ra18 (Mar 02 2011) ISSN: 1946-6242 [Electronic] United States
PMID21368223 (Publication Type: Journal Article)
Chemical References
  • Oligonucleotides, Antisense
  • Survival of Motor Neuron 1 Protein
  • Survival of Motor Neuron 2 Protein
Topics
  • Animals
  • Disease Models, Animal
  • Drug Delivery Systems
  • Humans
  • Macaca fascicularis
  • Mice
  • Motor Neurons (physiology)
  • Muscular Atrophy, Spinal (genetics, pathology, physiopathology, therapy)
  • Neuromuscular Junction (ultrastructure)
  • Oligonucleotides, Antisense (administration & dosage, genetics, pharmacokinetics, therapeutic use)
  • RNA Splicing
  • Spinal Cord (pathology, physiopathology)
  • Survival of Motor Neuron 1 Protein (genetics)
  • Survival of Motor Neuron 2 Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: